- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02716337
Target Versus Standard Human Milk Fortification in Very Low Birth Weight Preterm Infants
March 17, 2016 updated by: Prof. Pier Mannuccio Mannucci, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
The prevention of postnatal growth failure in very low birth weight (VLBW) preterm infants is of utmost importance.
Standard fortification is the most commonly used supplementation practice but it does not consider the native variability of human milk.
Data on efficacy and safety of prolonged target fortification are scarce.
The investigators performed a prospective interventional study in VLBW preterm infants, exclusively fed with human milk, to test efficacy and metabolic safety of target fortification in these preterm infants.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The prevention of postnatal growth failure in very low birth weight (VLBW) preterm infants is of utmost importance.
Fortified human milk is the goal for preterm infants' nutrition.
Standard fortification is the most commonly used and safe supplementation practice but it does not consider the native variability of human milk.
Data on efficacy and safety of prolonged target fortification are scarce.
Prospective interventional study was conducted in VLBW preterm infants, exclusively fed with human milk.
Twenty-four hour collected pools of human milk were analyzed and targeted human milk fortification was performed during hospitalization.
Weekly growth and daily growth velocity were compared with that of an historical group of VLBW preterm infants that had received standard fortified human milk.
Osmolality, metabolic and gastrointestinal tolerance were monitored.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Early Phase 1
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion criteria:
- Birth weight < 1500 grams
- Gestational age < 32 weeks
- Birth weight > 10th percentile according to Fenton' growth chart
- Exclusively breast feeding during the entire hospital stay
Exclusion criteria:
- Presence of congenital malformations that could affect growth (congenital diseases, chromosomal abnormalities, chronic lung disease, severe brain disease, severe metabolic, cardiac or gastrointestinal diseases)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Intervention group
In the intervention group VLBW infants were fed target fortified human milk Growth and safety were compared to a historical group of VLBW infants fed with standard fortified human milk
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Daily growth velocity (g/kg/day)
Time Frame: From the beginning of human milk fortification until the end of hospitalization (mean period of treatment 4-5 weeks)
|
From the beginning of human milk fortification until the end of hospitalization (mean period of treatment 4-5 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
weekly weight increase (g/week)
Time Frame: From the beginning of human milk fortification until the end of hospitalization (mean period of treatment 4-5 weeks)
|
From the beginning of human milk fortification until the end of hospitalization (mean period of treatment 4-5 weeks)
|
weekly length increase (cm/week)
Time Frame: From the beginning of human milk fortification until the end of hospitalization (mean period of treatment 4-5 weeks)
|
From the beginning of human milk fortification until the end of hospitalization (mean period of treatment 4-5 weeks)
|
head circumference increase (cm/week)
Time Frame: From the beginning of human milk fortification until the end of hospitalization (mean period of treatment 4-5 weeks)
|
From the beginning of human milk fortification until the end of hospitalization (mean period of treatment 4-5 weeks)
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
osmolality of fortified human milk
Time Frame: From the beginning of human milk fortification until the end of hospitalization (mean period of treatment 4-5 weeks)
|
From the beginning of human milk fortification until the end of hospitalization (mean period of treatment 4-5 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2014
Primary Completion (Actual)
March 1, 2015
Study Registration Dates
First Submitted
March 7, 2016
First Submitted That Met QC Criteria
March 17, 2016
First Posted (Estimate)
March 23, 2016
Study Record Updates
Last Update Posted (Estimate)
March 23, 2016
Last Update Submitted That Met QC Criteria
March 17, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Target HM fortification
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postnatal Growth Failure of Preterm Infants
-
PBM NutritionalsCompletedGrowth of InfantsUnited States, Honduras
-
Mead Johnson NutritionCompletedGrowth of Term InfantsUnited States
-
Mead Johnson NutritionCompletedGrowth of Term InfantsUnited States
-
Mead Johnson NutritionCompleted
-
Zekai Tahir Burak Women's Health Research and Education...CompletedCompare of Effectiveness Cycled Light and Near Darkness on Growth in Preterm InfantsTurkey
-
The University of Texas Health Science Center,...UnknownMalnutrition | Growth Failure | Nutrition | Nutrition Disorder, Infant | Growth Failure in Medically Complex Infants | Malnutrition in Medically Complex Infants | Nutrition in Medically Complex InfantsUnited States
-
Universidad Autónoma de QuerétaroNUCITEC S.A. de C.V.CompletedGrowth & Development | Formula Feeding of Healthy Full Term Infants | Breast Feeding of Healthy Full Term InfantsMexico
-
Chiayi Christian HospitalCompletedGrowth | Preterm Infants | MCT Oil MassageTaiwan
-
Assiut UniversityUnknownInfants Aged One Month to 2 Years , Infants With Any Type of Feeding (Breast or Artificial or Weaned Attend Assiut University Children Hospital )
-
All India Institute of Medical Sciences, New DelhiMaulana Azad Medical College; Sir Ganga Ram Hospital; Vardhman Mahavir Medical... and other collaboratorsCompletedPrematurity of Fetus | Postnatal Growth DisorderIndia
Clinical Trials on Addition of human milk fortifiers according to human milk analysis
-
University of TennesseeCompletedEnteral Nutrition | Human Milk | Fortification | Premature; InfantUnited States
-
The University of Texas Health Science Center at...RecruitingNeonatal Abstinence SyndromeUnited States
-
KK Women's and Children's HospitalNot yet recruitingGrowth Failure | Very Low Birth Weight Infant | Donor Breast MilkSingapore
-
Imperial College LondonUnknownInsulin Resistance | Adiposity | Metabolomic Profile | microRNA ProfileUnited Kingdom
-
Loyola UniversityRecruitingStress | Infant DevelopmentUnited States
-
Seattle Children's HospitalRecruitingIntestinal Obstruction | Gastroschisis | Hirschsprung Disease | Omphalocele | Gastrointestinal Complication | Midgut VolvulusUnited States
-
Hospital Universitario La PazCompletedPreterm | Very Low Birth Weight Infant | Food, Fortified | Feeding, BreastSpain
-
Crouse HospitalRecruitingNecrotizing Enterocolitis | Poor Growth in Extremely Preterm InfantsUnited States
-
Columbia UniversityRecruitingGrowth Failure | Growth Retardation | Prematurity; Extreme | Infant Nutrition Disorders | Failure to Thrive in NewbornUnited States
-
Vilnius UniversityUniversity of CagliariCompleted